These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 12837566)

  • 1. The KEEPER trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study.
    Morrell MJ; Leppik I; French J; Ferrendelli J; Han J; Magnus L
    Epilepsy Res; 2003 May; 54(2-3):153-61. PubMed ID: 12837566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial.
    Cereghino JJ; Biton V; Abou-Khalil B; Dreifuss F; Gauer LJ; Leppik I
    Neurology; 2000 Jul; 55(2):236-42. PubMed ID: 10908898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of levetiracetam (up to 2000 mg/day) in Taiwanese patients with refractory partial seizures: a multicenter, randomized, double-blind, placebo-controlled study.
    Tsai JJ; Yen DJ; Hsih MS; Chen SS; Hiersemenzel R; Edrich P; Lai CW
    Epilepsia; 2006 Jan; 47(1):72-81. PubMed ID: 16417534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial.
    Glauser TA; Pellock JM; Bebin EM; Fountain NB; Ritter FJ; Jensen CM; Shields WD
    Epilepsia; 2002 May; 43(5):518-24. PubMed ID: 12027913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I
    Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
    Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of levetiracetam in clinical practice: results of the SKATE trial from Belgium and The Netherlands.
    Lambrechts DA; Sadzot B; van Paesschen W; van Leusden JA; Carpay J; Bourgeois P; Urbain E; Boon PA
    Seizure; 2006 Sep; 15(6):434-42. PubMed ID: 16893660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
    Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of levetiracetam as adjunctive treatment of refractory partial seizures in a multicentre open-label single-arm trial in Korean patients.
    Heo K; Lee BI; Yi SD; Huh K; Kim JM; Lee SA; Shin DJ; Song HK; Lee SK; Kim JY; Lu S; Dubois C; Tonner F
    Seizure; 2007 Jul; 16(5):402-9. PubMed ID: 17369059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Safety of levetiracetam as adjunctive therapy in epilepsy: the SKATE trial in Spain].
    Salas-Puig J; Serratosa JM; Viteri C; Gil-Nágel-Rein A;
    Rev Neurol; 2004 Jun 16-30; 38(12):1117-22. PubMed ID: 15229822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
    Abou-Khalil B; Hemdal P; Privitera MD
    Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of levetiracetam as adjunctive therapy in Japanese patients with uncontrolled partial-onset seizures.
    Inoue Y; Yagi K; Ikeda A; Sasagawa M; Ishida S; Suzuki A; Yoshida K;
    Psychiatry Clin Neurosci; 2015 Oct; 69(10):640-8. PubMed ID: 25854635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam add-on for drug-resistant localization related (partial) epilepsy.
    Chaisewikul R; Privitera MD; Hutton JL; Marson AG
    Cochrane Database Syst Rev; 2001; (1):CD001901. PubMed ID: 11279737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of levetiracetam as adjunctive therapy in adult patients with uncontrolled partial epilepsy: the Asia SKATE II Study.
    Kwan P; Lim SH; Chinvarun Y; Cabral-Lim L; Aziz ZA; Lo YK; Tonner F; Beh K; Edrich P;
    Epilepsy Behav; 2010 May; 18(1-2):100-5. PubMed ID: 20462804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
    Uthman BM; Almas M; Emir B; Giordano S; Leon T
    Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures.
    Xiao Z; Li JM; Wang XF; Xiao F; Xi ZQ; Lv Y; Sun HB
    Eur Neurol; 2009; 61(4):233-9. PubMed ID: 19176965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.